The Puerarin improves renal function in STZ-induced diabetic rats by attenuating eNOS expression

Area of Science:

• Nephrology
• Pharmacology
• Diabetology

Background:

• Diabetic nephropathy (DN) is a leading cause of kidney failure.
• Endothelial nitric oxide synthase (eNOS) plays a role in DN development and progression.
• Puerarin is a traditional Chinese medicine used for kidney diseases.

Purpose of the Study:

• To investigate the renal protective effects of Puerarin in a rat model of diabetic nephropathy.
• To explore the potential mechanism involving eNOS expression.

Main Methods:

• Streptozotocin (STZ) induced diabetes in male Sprague-Dawley rats.
• Rats were divided into control, diabetic, and Puerarin-treated groups.
• Puerarin (100 mg/kg/day) was administered for 4 weeks.

Main Results:

• Puerarin treatment improved body weight, blood sugar, BUN, and SCr levels in diabetic rats.
• Puerarin reduced kidney ultrastructural damage.
• Puerarin attenuated eNOS expression in glomerular and tubular cells (p < 0.05).

Conclusions:

• Puerarin demonstrates significant renal protective effects in diabetic nephropathy.
• The protective mechanism may involve the regulation of eNOS expression.
• Puerarin shows potential as a therapeutic agent for diabetic nephropathy.